Loading stock data…
$35.33-0.02 (-0.06%)
NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, accessories, and services for men, women, and kids in North America, Europe, the Middle East, Africa, Greater China, the Asia Pacific, and Latin America.
NIKE, Inc. in the Consumer Cyclical sector is trading at $35.33 with a market capitalization of $53.6B. Wall Street consensus targets $38.04 (36 analysts), implying a +7.7% move over the next 12 months. The stock is currently near its 52-week low of $31.97, remaining 24.8% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $10.97B↓ | $11.28B↓ | $12.43B↑ | $11.72B↑ | $11.10B |
| Gross Profit | $5.39B↑ | $4.53B↓ | $5.04B↑ | $4.94B↑ | $4.47B |
| Operating Income | $1.31B↑ | $553.00M↓ | $1.01B↑ | $927.00M↑ | $321.00M |
| Net Income | $1.07B↑ | $520.00M↓ | $792.00M↑ | $727.00M↑ | $211.00M |
NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, accessories, and services for men, women, and kids in North America, Europe, the Middle East, Africa, Greater China, the Asia Pac...
Academic risk and quality models computed from NKE's own filings and price history, not from analyst opinion.
Mixed: 4 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z above the 2.99 safe threshold, so the model puts bankruptcy risk in its lowest band.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, above the current 37.7% reading.
Fama-French 5-factor market beta. The five factors explain 22% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-10-13.